AwardedSWEServices€29,500,000
DVD/240149 -Vaccine effectiveness, burden and impact studies
- Published
- Published 30 October 2025
- Deadline
- Closed 16 December 2025
Overview
The European Centre for Disease Prevention and Control awarded a contract worth €29.5 million on 13 March 2026 to a consortium comprising EPICONCEPT, HSE, INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE, ISCIII, and ORGANISMO AUTONOMO INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA to conduct vaccine effectiveness, disease burden and impact studies. The scope includes primary data collection in hospital and primary care settings across all age groups and special populations using existing VEBIS networks, as well as electronic health registry-based studies and ad hoc investigations including zoonotic influenza assessments.
Key details
- Country
- SWE
- Status
- Awarded
- Category
- Services
- Estimated value
- €29,500,000
- Procedure
- Open
- Published
- 30 October 2025
- Deadline
- Closed
Health services
Award outcome
- Award date
- 13 March 2026
- Contract period
- — → 20 February 2030
- EPICONCEPT
- HSE
- INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
- ISCIII
- ORGANISMO AUTONOMO INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 April 2026
Contract Notice
30 October 2025
Contracting authority
European Centre for Disease Prevention and Control
Procuring entitySolna, SWE
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.